Results 21 to 30 of about 548,176 (302)

Chronic heart failure

open access: yesAustralian Journal of Physiotherapy, 2008
Chronic heart failure (CHF) is a major healthcare problem. CHF is both physically and emotionally disabling and has a major impact on quality of life. Moreover, CHF has a long-term prognosis comparable to or worse than most common malignancies. 1 It is a frequent reason for unplanned hospital admissions, and has a major impact on healthcare resources ...
Mark T. Kearney, Helen Williams
openaire   +4 more sources

Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID‐19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital

open access: yesThe Journal of Clinical Hypertension, 2021
It is widely recognized that hypertension is one of the major risk factor for disease severity and mortality in patients with coronavirus disease 2019 (COVID‐19). However, type 2 diabetes mellitus (T2DM) and hypertension are frequent comorbid conditions,
Yuhui Sun   +7 more
doaj   +1 more source

Construction of a Non-Mutually Exclusive Decision Tree for Medication Recommendation of Chronic Heart Failure

open access: yesFrontiers in Pharmacology, 2022
Objective: Although guidelines have recommended standardized drug treatment for heart failure (HF), there are still many challenges in making the correct clinical decisions due to the complicated clinical situations of HF patients.
Yongyi Bai   +12 more
doaj   +1 more source

F2RL3 Methylation in the Peripheral Blood as a Potential Marker for the Detection of Coronary Heart Disease: A Case-Control Study

open access: yesFrontiers in Genetics, 2022
Background and Aims: Previous work has shown the association between blood-based methylation of coagulation factor II receptor-like 3 gene (F2RL3) and cardiovascular mortality in Caucasians.
Xiaojing Zhao   +10 more
doaj   +1 more source

What can we learn from SOCRATES: more questions than answers? [PDF]

open access: yes, 2017
This editorial refers to ‘Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) Study’, by B ...
Cleland, John G.F., Mueller, Christian
core   +1 more source

Using artificial intelligence in the development of diagnostic models of coronary artery disease with imaging markers: A scoping review

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundCoronary artery disease (CAD) is a progressive disease of the blood vessels supplying the heart, which leads to coronary artery stenosis or obstruction and is life-threatening.
Xiao Wang   +28 more
doaj   +1 more source

Physiological monitoring in the complex multimorbid heart failure patient - Conclusions. [PDF]

open access: yes, 2019
Comorbidities are increasingly recognized as crucial components of the heart failure syndrome. Main specific challenges are polypharmacy, poor adherence to treatments, psychological aspects, and the need of monitoring after discharge.
Böhm, M   +4 more
core   +1 more source

Iron deficiency in chronic heart failure: case-based practical guidance [PDF]

open access: yes, 2021
In patients with chronic heart failure, iron deficiency, even in the absence of anaemia, can aggravate the underlying disease and have a negative impact on clinical outcomes and quality of life.
Comín Colet, Josep   +3 more
core   +1 more source

A Multi-Task Neural Network Architecture for Renal Dysfunction Prediction in Heart Failure Patients With Electronic Health Records

open access: yesIEEE Access, 2019
Renal dysfunction, which is associated with bad clinical outcomes, is one of the most common complications of heart failure (HF). Timely prediction of renal dysfunction can help medical staffs intervene early to avoid catastrophic consequences.
Binhua Wang   +9 more
doaj   +1 more source

Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methyl [PDF]

open access: yes, 2014
Background: A phase 3 randomized clinical trial was designed to test whether bardoxolone methyl, a nuclear factor erythroid-2–related factor 2 (Nrf2) activator, slows progression to end-stage renal disease in patients with stage 4 chronic kidney disease
Bakris, George L.   +10 more
core   +4 more sources

Home - About - Disclaimer - Privacy